These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 6865186

  • 1. [Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension].
    Erina EV, Charyev KhE, Oshchepkova EV.
    Kardiologiia; 1983 Apr; 23(4):53-9. PubMed ID: 6865186
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effect of the beta-adrenergic receptor blocker corgard (nadolol) and its effect on hemodynamics in hypertensive patients].
    Charyev KhE, Erina EV.
    Kardiologiia; 1983 Aug; 23(8):17-21. PubMed ID: 6620829
    [Abstract] [Full Text] [Related]

  • 3. [Clinical use of chloranolol (tobanum) in essential hypertension patients].
    Charyev KhE, Erina EV, Ibraimova AS, Prokopova TN, Iurenev AP.
    Kardiologiia; 1986 Dec; 26(12):86-9. PubMed ID: 3560618
    [Abstract] [Full Text] [Related]

  • 4. [Changes in peripheral arterial blood flow and venous capacity in arterial hypertension and their relationship to the antihypertensive action of beta blockers].
    Caesar K, Saborowski F, Lang R, Meurer KA, Kaufmann W.
    Verh Dtsch Ges Kreislaufforsch; 1977 Dec; 43():218. PubMed ID: 613580
    [No Abstract] [Full Text] [Related]

  • 5. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM, Madkour MA, Mossallam R.
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():473s-475s. PubMed ID: 7449301
    [Abstract] [Full Text] [Related]

  • 6. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H, Glogar D, Uhlir H, Leisch F, Niederberger M, Steinbach K.
    Wien Klin Wochenschr; 1978 Sep 01; 90(16):611-6. PubMed ID: 695651
    [Abstract] [Full Text] [Related]

  • 7. Haemodynamic changes during treatment of arterial hypertension with atenolol (Tenormin).
    Jensen HA, Rasmussen K, Mosbaek N.
    Dan Med Bull; 1980 Jul 01; 27(3):153-5. PubMed ID: 7438801
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of the haemodynamic interaction between atenolol, a cardioselective beta-adrenoreceptor-blocking agent, and chlorthalidone in hypertensive patients.
    Velasco M, Guevara J, Morillo J, Ramírez A, Urbina-Quintana A, Hernandez-Pieretti O.
    Clin Sci (Lond); 1979 Dec 01; 57 Suppl 5():363s-365s. PubMed ID: 396082
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of hypertension with the cardioselective beta-adrenergic blockader tenormin].
    Charyev KhE, Iurenev AP, Erina EV.
    Ter Arkh; 1983 Dec 01; 55(9):51-6. PubMed ID: 6635980
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension.
    Jensen HA, Rasmussen K, Mosbaek N.
    Clin Sci Mol Med Suppl; 1976 Dec 01; 3():525s-526s. PubMed ID: 799562
    [Abstract] [Full Text] [Related]

  • 11. [Ambulatory treatment of hypertension with the beta-blockader corgard (nadolol)].
    Charyev KhE, Erina EV, Iurenev AP, Lediasheva GA.
    Ter Arkh; 1984 Dec 01; 56(11):43-6. PubMed ID: 6523386
    [Abstract] [Full Text] [Related]

  • 12. Atenolol (Tenormin) - another "cardioselective" beta-blocker for hypertension.
    Med Lett Drugs Ther; 1982 Feb 05; 24(602):15-6. PubMed ID: 7057740
    [No Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED, Ketelhut R, Kaesser UR, Losem CJ, Messerli FH.
    Am J Cardiol; 1991 Aug 15; 68(5):509-14. PubMed ID: 1678580
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients.
    Amery A, Billiet L, Boel A, Fagard R, Reybrouck T, Willems J.
    Am Heart J; 1976 May 15; 91(5):634-42. PubMed ID: 773142
    [Abstract] [Full Text] [Related]

  • 15. A comparison of antihypertensive effects between two formulations of atenolol: tenolol and tenormin.
    Chiang HT, Hou ZY, Lee DK, Wu TL, Chen CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May 15; 55(5):366-70. PubMed ID: 7641121
    [Abstract] [Full Text] [Related]

  • 16. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa, Brin VB.
    Ter Arkh; 1983 May 15; 55(5):81-3. PubMed ID: 6137077
    [No Abstract] [Full Text] [Related]

  • 17. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L, Karlberg BE, Aberg H, Westerlund A, Jameson S, Henningsen NC.
    Acta Med Scand; 1976 May 15; 199(4):257-61. PubMed ID: 4956
    [Abstract] [Full Text] [Related]

  • 18. Atenolol once-daily in hypertension.
    Jeffers TA, Webster J, Petrie JC, Barker NP.
    Br J Clin Pharmacol; 1977 Oct 15; 4(5):523-7. PubMed ID: 334211
    [Abstract] [Full Text] [Related]

  • 19. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G, Franciosa JA, Gimenez HJ, Cohn JN.
    Hypertension; 1981 Oct 15; 3(2):262-8. PubMed ID: 6111532
    [Abstract] [Full Text] [Related]

  • 20. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM, Madkour MA, Mossallam R.
    Circulation; 1980 Nov 15; 62(5):1036-45. PubMed ID: 7418154
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.